ECSP034662A - PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS - Google Patents

PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Info

Publication number
ECSP034662A
ECSP034662A ECSP034662A ECSP034662A EC SP034662 A ECSP034662 A EC SP034662A EC SP034662 A ECSP034662 A EC SP034662A EC SP034662 A ECSP034662 A EC SP034662A
Authority
EC
Ecuador
Prior art keywords
compounds used
inhibitors
protein
pirazol
aurora
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jean Damien Charrier
Andrew Miller
Ronald Marcelius Knegtel
David Bebbington
Julian Golec
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ECSP034662A publication Critical patent/ECSP034662A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a la química medicinal y a los compuestos que son inhibidores de Aurora -2 protein quinasas. La invención además se refiere a compuestos que son inhibidores de Aurora -2 protein quinasas. La invención además se refiere a métodos para tratar enfermedades asociadas con protein quinasas, especialmente enfermedades asociadas con Aurora -2, tal como el cáncerThe present invention relates to medicinal chemistry and compounds that are inhibitors of Aurora -2 protein kinases. The invention also relates to compounds that are inhibitors of Aurora -2 protein kinases. The invention further relates to methods for treating diseases associated with protein kinases, especially diseases associated with Aurora -2, such as cancer.

ECSP034662 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS ECSP034662A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25788700P 2000-12-21 2000-12-21

Publications (1)

Publication Number Publication Date
ECSP034662A true ECSP034662A (en) 2003-07-25

Family

ID=34078813

Family Applications (2)

Application Number Title Priority Date Filing Date
ECSP034662 ECSP034662A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS
ECSP034663 ECSP034663A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
ECSP034663 ECSP034663A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Country Status (2)

Country Link
EC (2) ECSP034662A (en)
ZA (8) ZA200304472B (en)

Also Published As

Publication number Publication date
ZA200304472B (en) 2004-06-25
ZA200304469B (en) 2004-06-24
ZA200304468B (en) 2004-06-24
ZA200304474B (en) 2004-06-25
ZA200304471B (en) 2004-06-24
ZA200304470B (en) 2004-06-24
ZA200304473B (en) 2004-06-24
ECSP034663A (en) 2003-07-25
ZA200304475B (en) 2004-06-24

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (en) USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS.
MXPA05012573A (en) Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors.
BRPI0418031A (en) phosphonate-substituted kinase inhibitors
UY27943A1 (en) COMPOSITIONS AND METHODS TO TREAT CRNCER USING ANTIBODY IMMUNOCATE PLAYS FOR CD44 CYTOTNXICS AND CHEMOTHERAPCUTIC AGENTS
ECSP066362A (en) INHIBITORS OF MYTHOTIC KINESINE.
BRPI0616630B8 (en) substituted pyrazole compounds
EA200870415A1 (en) QUINAZOLINS TO INHIBIT PDK 1
BRPI0416981A (en) compounds for treating cell proliferative diseases
UY27234A1 (en) NOVELTY INHIBITORS OF TYROSINE KINASE
HN2000000051A (en) USEFUL HETEROCICLIC DERIVATIVES AS ANTI-TARGET AGENTS
SV2003001493A (en) SUBSTITUTED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
DK1255537T3 (en) Farnesyl protein transferase inhibitors for the treatment of breast cancer
BRPI0513310A (en) tetrapeptide analogs
SV2004001459A (en) 2- (PIRIDIN-2-ILAMINO) -PIRIDO [2,3-D] PIRIMIDIN-7-ONAS REF. PC20501
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
DOP2004000949A (en) PIRROLO DERIVATIVES [3,4-C] PIRAZOL ASSETS AS KINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME
CR20120009A (en) 2-INDOLINONES REPLACED WITH PROTEINQUINASE INHIBITING PIRROLS (DIVISIONAL EXP. 6728)
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
CR10072A (en) PIRIMIDINIL-ARIL-UREA DERIVATIVES THAT ARE FGF INHIBITORS
ATE424388T1 (en) MITOTIC KINESIN INHIBITORS
ATE447577T1 (en) MITOTIC KINESIN INHIBITORS
ATE372341T1 (en) INHIBITORS OF MITOTIC KINESIN
CR7877A (en) DERIVATIVES OF 4-TETRAZOLIL-4-PHENYLPIPERIDINE TO TREAT PAIN
DE60021381D1 (en) CHINONIC COMPOUNDS FOR THE TREATMENT OF DISEASES
BR122018009866B8 (en) methods for preparing aminocyclohexyl ether compounds and intermediate compounds